NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE CAP
Sotera Health Co. SHC
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.2B
▲ 5.7% vs FY2024
EPS · FY25
$0.27
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
15.4%
Net margin · FY25
6.7%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.2B
Revenue, FY2025 · full 7-year series below
Revenue
Net income
7 cents of every revenue dollar became profit this year.
Per share
USD 0.27
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
15.4%
Return on equity, FY2025
ROE
Operating margin12.7%
Net margin6.7%
Return on assets2.5%
Each USD of equity produced 15 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+7.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.1%
+7.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.3B
total assets, end of FY2025
Total assetsUSD 3.3B
EquityUSD 606.0M
CashUSD 344.6M
Gross debtUSD 2.1B
Net debtUSD 1.8B
Current ratio2.46×
Net debt stands at 296% of equity.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
1.2
1.1
1.0
1.0
0.9
0.8
0.8
Operating income $B
0.1
0.1
0.1
0.2
0.3
0.2
0.2
EBITDA $B
0.2
0.2
0.2
0.3
0.3
0.3
0.3
Income tax $B
0.1
0.1
0.1
−0.0
0.1
−0.0
0.0
Net income $B
0.1
0.0
0.1
−0.2
0.1
−0.0
−0.0
EPS, diluted $
0.27
0.16
0.18
−0.83
0.41
−0.16
−0.09
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
0
−0
−3315
ROE %
15.4
10.5
12.9
−49.9
22.5
−8.5
·
Shares out B
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
26 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed